ALEXANDRIA, Va., Oct. 21 -- United States Patent no. 12,766,016, issued on Oct. 20, was assigned to Bosto Scientific Scimed Inc. (Maple Grove, Minn.).
"Lumen apposing stent to deliver targeted therapy" was invented by Kevin Walsh (Wellesly, Mass.), Sean P Fleury (Princeton, Mass.), David Callaghan (Ashland, Mass.), Laura Emily Richards (Worcester, Mass.), John Thomas Favreau (Spencer, Mass.) and James J Scutti (Norwell, Mass.).
According to the abstract* released by the U.S. Patent & Trademark Office: "Devices, systems, and methods for delivering targeted therapy to tissue at a treatment site with the use of a stent. The targeted therapy may include a functional and/or therapeutic agent separate from the stent, or a component of a functio...